| Contract Research Organization (CRO) | Drug discovery research including medicinal chemistry, biology, pharmacology, DMPK, and toxicology studies. | Proprietary AI tools, global client relationships, regulatory compliance and dedicated facilities. | Global pharmaceutical and biotech companies (B2B focus). | Integrated discovery services combining chemistry and biology. | 626 | 37 | Project-based contracts and retainer fees from pharma innovators. | Fixed price and milestone-based engagements. | Adoption of AI, expansion of integrated drug discovery services, and increased outsourcing by pharma. | Discovery Chemistry, Biology, DMPK, Preclinical Services |
| Contract Development and Manufacturing Organization (CDMO) | Process development, clinical and commercial scale manufacturing of APIs and complex drug modalities. | Regulatory approvals (USFDA, PMDA), scalable GMP facilities, technology adoption and sustainability certifications. | Large pharmaceutical innovators and manufacturers (B2B). | Commercial scale manufacturing, high-potency APIs, peptide synthesis. | 1068 | 63 | Manufacturing contracts and supply agreements. | Long-term contract manufacturing with variable pricing based on volumes and complexity. | Capacity expansions, advanced modality manufacturing, strong late-phase and commercial molecule pipeline. | API Manufacturing, Peptides, Antibody Drug Conjugates (ADCs) |
